HIV epidemiology and breakthroughs in prevention 30 years into the AIDS epidemic

Topics in Antiviral Medicine

Volumn 19, Issue 2, 2011, Pages 38-46

  Buchbinder, Susan P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

CHEMOPROPHYLAXIS; COMORBIDITY; CONFERENCE PAPER; DISEASE TRANSMISSION; ETHNIC AND RACIAL GROUPS; FEMALE; HEALTH; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; METHODOLOGY; PANDEMIC;

ANTI-HIV AGENTS; CHEMOPREVENTION; COMORBIDITY; DISEASE TRANSMISSION, INFECTIOUS; FEMALE; HIV INFECTIONS; HUMANS; MALE; PANDEMICS; POPULATION GROUPS; WORLD HEALTH;

EID: 84855401223     PISSN: 21615861     EISSN: 21615853     Source Type: Journal    
DOI: None     Document Type: Article

References (4)

1. World Bank. Malawi and Tanzania research shows promise in preventing HIV and sexually transmitted infections. July 18, 2010. http://go.worldbank.org/ YVMPZBKC00. Accessed April 17, 2011.
2. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168-1174.
3. Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587-2599.
4. Institute of Medicine Board on Global Health. Preparing for the future of HIV/ AIDS in Africa: a shared responsibility. November 29, 2010. http://www. iom.edu/Reports/2010/Preparing-for-the-Future-of-HIVAIDS-in-Africa-A-Shared-Responsibility.aspx. Accessed April 17, 2011.